Stay updated on Pembrolizumab & Blinatumomab in ALL Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Blinatumomab in ALL Clinical Trial page.

Latest updates to the Pembrolizumab & Blinatumomab in ALL Clinical Trial page
- Check4 days agoChange DetectedThe page now displays 'Results Submitted' instead of 'No Results Posted', indicating that trial results have been submitted.SummaryDifference0.1%

- Check11 days agoChange DetectedUpdated revision label to v3.5.0 and removed v3.4.3.SummaryDifference0.1%

- Check18 days agoChange DetectedRevision tag updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check46 days agoChange DetectedAdded Revision: v3.4.2; removed the prior notices about funding lapses and operating status (Revision: v3.4.1).SummaryDifference0.4%

- Check54 days agoChange DetectedNotice about government funding lapse added, stating the NIH Clinical Center is open and directing users to opm.gov for updates. The site revision label was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check61 days agoChange DetectedAdded a glossary display option and updated footer/version information to show 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Removed the older items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab & Blinatumomab in ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Blinatumomab in ALL Clinical Trial page.